Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
FDA Approval of Aducanumab
Neurimmune welcomes the news that the U.S. Food and Drug Administration (FDA) has approved Biogen‘s […]
NIIMBL Announces $4.6M to Fund 10 New Biopharmaceutical Manufacturing Projects
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce funding for […]
Tata Digital to Acquire Majority Stake in India’s Leading Online Healthcare Marketplace 1MG
Tata Digital Limited, a 100% subsidiary of Tata Sons Private Limited, will acquire a majority […]
ViAqua Therapeutics Announces $4.3 Million Investment for RNA-based Aquaculture Health Platform
ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and […]
Blueberry Therapeutics Secures £750,000 Investment from NPIF - Maven Equity Fund
NPIF – Maven Equity Finance, managed by Maven Capital Partners (“Maven”) and part of the […]
U.S. FDA Approves Prevnar 20™, Pfizer’s Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or Older
Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved […]
Half a Million COVID Jabs Booked in ‘Glastonbury Rush’ This Morning
The NHS saw a welcome surge in demand for vaccines this morning as half a […]
London’s First Dedicated Detox Unit for Homeless People Set to Open
London’s first dedicated detox unit for homeless people is set to open on 14 June […]
Camber Pharma Launches Generic Kaletra
Camber Pharmaceuticals is pleased to announce that it has launched Lopinavir and RitonavirTablets, which is […]
New App Arms People with Strategies to Fight Chronic Pain, Live a Fuller Life
The Arthritis Foundation has released a mobile app to serve as a new tool for […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more